Skip to main content
Diagnos Inc logo

Diagnos Inc — Investor Relations & Filings

Ticker · ADK ISIN · CA2524423068 LEI · 254900ZF529VWZDVUS82 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 697 across all filing types
Latest filing 2023-01-13 Capital/Financing Update
Country CA Canada
Listing TSXV ADK

About Diagnos Inc

https://www.diagnos.com/

Diagnos Inc. is a technology company specializing in software-based services for the healthcare sector, focusing on the early detection of critical health problems. The company leverages its proprietary FLAIRE Artificial Intelligence (AI) platform, which combines contextual imaging and data analysis to develop algorithms, process images, and analyze data. A primary application of this technology is AI retina analysis for screening and monitoring diseases, such as diabetes, to prevent vision loss. Diagnos aims to enable digital transformation in healthcare by providing cost-effective early detection solutions to primary care facilities and specialists across international markets, including North America and Latin America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the closing of a private placement financing by DIAGNOS Inc. It details the issuance of convertible debentures and warrants, the terms of these securities, the amount raised, and the intended use of proceeds. There is no financial statement or comprehensive financial report included. The document is focused on capital raising activity and financing terms, which aligns with the Capital/Financing Update category. The document length is 4129 characters, which is consistent with a typical announcement rather than a full report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-01-13 English
Material change report (amended) - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed under National Instrument 51-102. It details a private placement financing transaction, including the issuance of convertible debentures and warrants, insider participation, and related party considerations. The content focuses on a capital raising event and financing details rather than a full financial report, earnings release, or management discussion. The document length is 4431 characters, which is relatively short but contains substantive information about the financing transaction itself, not just an announcement or a certification. Therefore, it fits best under the category for Capital/Financing Update (CAP).
2022-12-23 English
Material change report (amended) - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a Form 51-102F3 Material Change Report filed under National Instrument 51-102, which is a regulatory filing used to disclose material changes in a company. The content describes a private placement financing transaction, including details about the securities issued, related party participation, and regulatory exemptions. The document length is 4050 characters, which is relatively short and focused on a specific event rather than a comprehensive financial report. It is not an annual or interim report, earnings release, or management discussion. It is also not a proxy, governance, or legal proceeding document. The primary purpose is to inform about a material change related to capital raising, fitting the category of Capital/Financing Update (CAP).
2022-12-23 English
Report of exempt distribution excluding schedule 1 of Form 5.pdf
Regulatory Filings
2022-12-16 English
Material change report - English.pdf
Regulatory Filings
2022-12-16 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release dated December 15, 2022, announcing additional information related to the closing of a private placement by DIAGNOS Inc. It details the payment of a cash commission and issuance of finder’s warrants as part of the private placement. There is no financial statement, detailed financial analysis, or regulatory form attached. The content focuses on financing activity, specifically the closing of a private placement and related terms. The document length is short (2014 characters), and it is not a report or certification but an update on financing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-12-15 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.